Survey shows dim faith in Lilly, Pfizer Alzheimer's drugs

(Reuters) - Institutional investors doubt that treatments for Alzheimer's disease being developed by Pfizer Inc and Eli Lilly will achieve the main goals of their ongoing late-stage trials, but hopes are running far higher for the Pfizer drug, according to a survey by ISI Group Inc.

Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/uBPFQ2qO-5U/us-alzheimers-survey-idUSBRE85I1S620120619

one day phlebotomy certification phlebotomy training schools phlebotomy certification maryland